Comparison of Technosphere Insulin Inhalation Powder & Subcutaneous Rapid-Acting Analog in Subjects With Type 1 Diabetes

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

September 30, 2012

Study Completion Date

January 31, 2013

Conditions

Type 1 Diabetes Mellitus

Interventions

DRUG

Technosphere Insulin Inhalation Powder

Inhalation Powder using the Gen2C inhaler

DRUG

Rapid Acting Analog

Subcutaneous Injection

Trial Locations (1)

Profil Institute for Clinical Research, Chula Vista